Callan Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.17M	Buy	6,040 +4,135	+217%	+$2.17M	0.1%	213
2025 Q1	$1.21M	Buy	1,905 +336	+21%	+$213K	0.09%	190
2024 Q4	$1.12M	Buy	+1,569	New	+$1.12M	0.07%	229
2023 Q2	–	Sell	-786	Closed	-$646K	–	145
2023 Q1	$646K	Buy	+786	New	+$646K	0.16%	82